$TGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in THERAGENICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in THERAGENICS CORP. Get notifications about new insider transactions in THERAGENICS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | D | 1.71 | 58,200 | 99,522 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | D | 1.44 | 47,000 | 67,680 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | D | 0.93 | 34,000 | 31,620 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Sell | D | 2.20 | 230,250 | 506,550 | 0 | 230.3 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Sell | D | 2.20 | 68,162 | 149,956 | 230,250 | 298.4 K to 230.3 K (-22.84 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Option Exercise | D | 1.71 | 58,200 | 99,522 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Option Exercise | D | 1.44 | 47,000 | 67,680 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Sell | D | 2.20 | 219,175 | 482,185 | 0 | 219.2 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Sell | D | 2.20 | 54,308 | 119,478 | 219,175 | 273.5 K to 219.2 K (-19.86 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Option Exercise | D | 1.71 | 58,200 | 99,522 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Option Exercise | D | 1.44 | 47,000 | 67,680 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Option Exercise | D | 0.93 | 34,000 | 31,620 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Sell | D | 2.20 | 235,962 | 519,116 | 0 | 236 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Sell | D | 2.20 | 68,182 | 150,000 | 235,962 | 304.1 K to 236 K (-22.42 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | D | 1.71 | 71,100 | 121,581 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | D | 1.44 | 57,000 | 82,080 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | D | 0.93 | 40,000 | 37,200 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Sell | D | 2.20 | 301,308 | 662,878 | 0 | 301.3 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Sell | D | 2.20 | 136,364 | 300,001 | 301,308 | 437.7 K to 301.3 K (-31.16 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Option Exercise | D | 1.71 | 67,900 | 116,109 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Option Exercise | D | 1.44 | 52,000 | 74,880 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Option Exercise | D | 0.93 | 34,000 | 31,620 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Sell | D | 2.20 | 532,798 | 1,172,156 | 0 | 532.8 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | D | 1.71 | 109,900 | 187,929 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | D | 1.44 | 70,400 | 101,376 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | D | 0.93 | 80,000 | 74,400 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Sell | D | 2.20 | 946,523 | 2,082,351 | 0 | 946.5 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Option Exercise | D | 1.33 | 5,000 | 6,650 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Option Exercise | D | 1.02 | 5,000 | 5,100 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Sell | D | 2.20 | 139,000 | 305,800 | 0 | 139 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Option Exercise | D | 1.33 | 5,000 | 6,650 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Option Exercise | D | 1.02 | 5,000 | 5,100 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Sell | D | 2.20 | 117,318 | 258,100 | 0 | 117.3 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Option Exercise | D | 1.33 | 5,000 | 6,650 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Option Exercise | D | 1.02 | 5,000 | 5,100 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Sell | D | 2.20 | 209,550 | 461,010 | 0 | 209.6 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Option Exercise | D | 1.33 | 5,000 | 6,650 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Option Exercise | D | 1.02 | 5,000 | 5,100 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Sell | D | 2.20 | 90,000 | 198,000 | 0 | 90 K to 0 (-100.00 %) |
Oct 31 2013 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Option Exercise | D | 1.33 | 5,000 | 6,650 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Option Exercise | D | 1.02 | 5,000 | 5,100 | 0 | |
Oct 31 2013 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Sell | D | 2.20 | 128,424 | 282,533 | 0 | 128.4 K to 0 (-100.00 %) |
May 20 2013 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 30,000 | 0 | 139,000 | 109 K to 139 K (+27.52 %) |
May 20 2013 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 30,000 | 0 | 117,318 | 87.3 K to 117.3 K (+34.36 %) |
May 20 2013 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 30,000 | 0 | 128,468 | 98.5 K to 128.5 K (+30.47 %) |
May 20 2013 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 30,000 | 0 | 209,550 | 179.6 K to 209.6 K (+16.71 %) |
May 20 2013 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 30,000 | 0 | 90,000 | 60 K to 90 K (+50.00 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Grant | A | 0.00 | 128,000 | 0 | 302,336 | 174.3 K to 302.3 K (+73.42 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 158,800 | 0 | 436,054 | 277.3 K to 436.1 K (+57.28 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Grant | A | 0.00 | 151,100 | 0 | 531,199 | 380.1 K to 531.2 K (+39.75 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Grant | A | 0.00 | 128,000 | 0 | 296,950 | 169 K to 297 K (+75.76 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Grant | A | 0.00 | 128,000 | 0 | 273,695 | 145.7 K to 273.7 K (+87.85 %) |
Feb 22 2013 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 276,400 | 0 | 944,667 | 668.3 K to 944.7 K (+41.36 %) |
Nov 19 2012 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 15,000 | 0 | 109,000 | 94 K to 109 K (+15.96 %) |
Nov 19 2012 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 15,000 | 0 | 87,318 | 72.3 K to 87.3 K (+20.74 %) |
Nov 19 2012 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 15,000 | 0 | 98,038 | 83 K to 98 K (+18.06 %) |
Nov 19 2012 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 15,000 | 0 | 179,550 | 164.6 K to 179.6 K (+9.12 %) |
Nov 19 2012 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 15,000 | 0 | 60,000 | 45 K to 60 K (+33.33 %) |
May 21 2012 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 15,000 | 0 | 94,000 | 79 K to 94 K (+18.99 %) |
May 21 2012 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 15,000 | 0 | 72,318 | 57.3 K to 72.3 K (+26.17 %) |
May 21 2012 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 15,000 | 0 | 82,098 | 67.1 K to 82.1 K (+22.36 %) |
May 21 2012 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 15,000 | 0 | 45,000 | 30 K to 45 K (+50.00 %) |
May 21 2012 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 15,000 | 0 | 164,550 | 149.6 K to 164.6 K (+10.03 %) |
Feb 28 2012 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Grant | A | 0.00 | 87,250 | 0 | 142,915 | 55.7 K to 142.9 K (+156.74 %) |
Feb 28 2012 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Grant | A | 0.00 | 87,250 | 0 | 168,777 | 81.5 K to 168.8 K (+107.02 %) |
Feb 28 2012 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Grant | A | 0.00 | 87,250 | 0 | 171,050 | 83.8 K to 171.1 K (+104.12 %) |
Feb 28 2012 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Grant | A | 0.00 | 101,800 | 0 | 377,181 | 275.4 K to 377.2 K (+36.97 %) |
Feb 28 2012 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 106,650 | 0 | 274,303 | 167.7 K to 274.3 K (+63.61 %) |
Feb 27 2012 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 164,800 | 0 | 665,248 | 500.4 K to 665.2 K (+32.93 %) |
May 24 2011 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 15,000 | 0 | 79,000 | 64 K to 79 K (+23.44 %) |
May 24 2011 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 15,000 | 0 | 66,629 | 51.6 K to 66.6 K (+29.05 %) |
May 24 2011 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 15,000 | 0 | 57,318 | 42.3 K to 57.3 K (+35.45 %) |
May 24 2011 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 15,000 | 0 | 149,550 | 134.6 K to 149.6 K (+11.15 %) |
May 24 2011 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 03 2011 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Payment of Exercise | F | 1.71 | 2,305 | 3,942 | 54,295 | 56.6 K to 54.3 K (-4.07 %) |
Mar 03 2011 | TGX | THERAGENICS CORP | SMITH BRUCE W | Executive Vice Pres ... | Payment of Exercise | F | 1.71 | 5,822 | 9,956 | 273,661 | 279.5 K to 273.7 K (-2.08 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | A | 1.71 | 71,100 | 121,581 | 249,300 | |
Mar 01 2011 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 37,400 | 0 | 165,946 | 128.5 K to 165.9 K (+29.09 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Option Exercise | A | 1.71 | 58,200 | 99,522 | 105,200 | |
Mar 01 2011 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Grant | A | 0.00 | 30,600 | 0 | 56,600 | 26 K to 56.6 K (+117.69 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Option Exercise | A | 1.71 | 58,200 | 99,522 | 162,400 | |
Mar 01 2011 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Grant | A | 0.00 | 30,600 | 0 | 83,800 | 53.2 K to 83.8 K (+57.52 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Option Exercise | A | 1.71 | 67,900 | 116,109 | 231,900 | |
Mar 01 2011 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Grant | A | 0.00 | 35,700 | 0 | 279,483 | 243.8 K to 279.5 K (+14.64 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | A | 1.71 | 58,200 | 99,522 | 149,200 | |
Mar 01 2011 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Grant | A | 0.00 | 30,600 | 0 | 80,806 | 50.2 K to 80.8 K (+60.95 %) |
Mar 01 2011 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | A | 1.71 | 109,900 | 187,929 | 574,300 | |
Mar 01 2011 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 57,900 | 0 | 498,767 | 440.9 K to 498.8 K (+13.13 %) |
Jun 03 2010 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Buy | P | 1.19 | 26,200 | 31,178 | 133,300 | 107.1 K to 133.3 K (+24.46 %) |
Jun 04 2010 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Buy | P | 1.16 | 1,250 | 1,450 | 134,550 | 133.3 K to 134.6 K (+0.94 %) |
May 20 2010 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Buy | P | 1.33 | 5,000 | 6,663 | 64,000 | 59 K to 64 K (+8.47 %) |
May 14 2010 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Option Exercise | A | 1.33 | 5,000 | 6,650 | 5,000 | |
May 14 2010 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 5,000 | 0 | 42,318 | 37.3 K to 42.3 K (+13.40 %) |
May 14 2010 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Option Exercise | A | 1.33 | 5,000 | 6,650 | 106,000 | |
May 14 2010 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 5,000 | 0 | 59,000 | 54 K to 59 K (+9.26 %) |
May 14 2010 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Option Exercise | A | 1.33 | 5,000 | 6,650 | 106,000 | |
May 14 2010 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 5,000 | 0 | 48,657 | 43.7 K to 48.7 K (+11.45 %) |
May 14 2010 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Option Exercise | A | 1.33 | 5,000 | 6,650 | 10,000 | |
May 14 2010 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 5,000 | 0 | 107,100 | 102.1 K to 107.1 K (+4.90 %) |
May 14 2010 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Option Exercise | A | 1.33 | 5,000 | 6,650 | 10,000 | |
May 14 2010 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
Mar 01 2010 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | A | 1.44 | 70,400 | 101,376 | 464,400 | |
Mar 01 2010 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 40,000 | 0 | 440,855 | 400.9 K to 440.9 K (+9.98 %) |
Mar 01 2010 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | A | 1.44 | 57,000 | 82,080 | 188,200 | |
Mar 01 2010 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 32,000 | 0 | 128,684 | 96.7 K to 128.7 K (+33.10 %) |
Mar 01 2010 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Option Exercise | A | 1.44 | 52,000 | 74,880 | 164,000 | |
Mar 01 2010 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Grant | A | 0.00 | 30,000 | 0 | 243,990 | 214 K to 244 K (+14.02 %) |
Mar 01 2010 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | A | 1.44 | 47,000 | 67,680 | 91,000 | |
Mar 01 2010 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Grant | A | 0.00 | 26,000 | 0 | 50,206 | 24.2 K to 50.2 K (+107.41 %) |
Mar 01 2010 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Option Exercise | A | 1.44 | 47,000 | 67,680 | 47,000 | |
Mar 01 2010 | TGX | THERAGENICS CORP | Plante Joseph | President, NeedleTe ... | Grant | A | 0.00 | 26,000 | 0 | 26,000 | 0 to 26 K |
Mar 01 2010 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Option Exercise | A | 1.44 | 47,000 | 67,680 | 104,200 | |
Mar 01 2010 | TGX | THERAGENICS CORP | Zeman Janet | President, CP Medic ... | Grant | A | 0.00 | 26,000 | 0 | 53,200 | 27.2 K to 53.2 K (+95.59 %) |
Feb 22 2010 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Buy | P | 1.35 | 50,000 | 67,300 | 102,100 | 52.1 K to 102.1 K (+95.97 %) |
Dec 01 2009 | TGX | THERAGENICS CORP | Lang Michael Francis | President, Galt Med ... | Option Exercise | D | 0.93 | 34,000 | 31,620 | 0 | |
Dec 01 2009 | TGX | THERAGENICS CORP | Lang Michael Francis | President, Galt Med ... | Option Exercise | D | 3.79 | 29,000 | 109,910 | 34,000 | |
Dec 01 2009 | TGX | THERAGENICS CORP | Lang Michael Francis | President, Galt Med ... | Sell | D | 0.00 | 24,750 | 0 | 3,250 | 28 K to 3.3 K (-88.39 %) |
May 18 2009 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Option Exercise | A | 1.02 | 5,000 | 5,100 | 101,000 | |
May 18 2009 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Grant | A | 0.00 | 5,000 | 0 | 54,000 | 49 K to 54 K (+10.20 %) |
May 18 2009 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Option Exercise | A | 1.02 | 5,000 | 5,100 | 5,000 | |
May 18 2009 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Grant | A | 0.00 | 5,000 | 0 | 37,318 | 32.3 K to 37.3 K (+15.47 %) |
May 18 2009 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Option Exercise | A | 1.02 | 5,000 | 5,100 | 52,100 | |
May 18 2009 | TGX | THERAGENICS CORP | Engwall K Wyatt | Director | Grant | A | 0.00 | 5,000 | 0 | 52,100 | 47.1 K to 52.1 K (+10.62 %) |
May 18 2009 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Option Exercise | A | 1.02 | 5,000 | 5,100 | 101,000 | |
May 18 2009 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Grant | A | 0.00 | 5,000 | 0 | 43,657 | 38.7 K to 43.7 K (+12.93 %) |
May 18 2009 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Option Exercise | A | 1.02 | 5,000 | 5,100 | 5,000 | |
May 18 2009 | TGX | THERAGENICS CORP | DAHLBERG KATHLEEN | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 18 2009 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Payment of Exercise | F | 1.10 | 794 | 873 | 24,206 | 25 K to 24.2 K (-3.18 %) |
Mar 18 2009 | TGX | THERAGENICS CORP | Routhier Ronald | President, NeedleTe ... | Payment of Exercise | F | 1.10 | 794 | 873 | 24,206 | 25 K to 24.2 K (-3.18 %) |
Mar 10 2009 | TGX | THERAGENICS CORP | MOODY CHARLES D JR | Director | Buy | P | 0.90 | 23,166 | 20,738 | 32,318 | 9.2 K to 32.3 K (+253.13 %) |
Mar 05 2009 | TGX | THERAGENICS CORP | HERNDON JOHN V | Director | Buy | P | 0.92 | 5,000 | 4,608 | 38,665 | 33.7 K to 38.7 K (+14.85 %) |
Mar 05 2009 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Payment of Exercise | F | 1.10 | 1,055 | 1,161 | 208,900 | 210 K to 208.9 K (-0.50 %) |
Mar 05 2009 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Payment of Exercise | F | 1.22 | 1,055 | 1,287 | 209,955 | 211 K to 210 K (-0.50 %) |
Mar 05 2009 | TGX | THERAGENICS CORP | SMITH BRUCE W | Exec. VP | Payment of Exercise | F | 0.88 | 2,950 | 2,596 | 211,010 | 214 K to 211 K (-1.38 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | SAUNDERS PETER A A | Director | Buy | P | 0.95 | 5,000 | 4,750 | 49,000 | 44 K to 49 K (+11.36 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Option Exercise | A | 0.93 | 34,000 | 31,620 | 44,000 | |
Mar 02 2009 | TGX | THERAGENICS CORP | Small C. Russell | VP, NeedleTech Prod ... | Grant | A | 0.00 | 15,000 | 0 | 25,000 | 10 K to 25 K (+150.00 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | Routhier Ronald | President, NeedleTe ... | Option Exercise | A | 0.93 | 34,000 | 31,620 | 44,000 | |
Mar 02 2009 | TGX | THERAGENICS CORP | Routhier Ronald | President, NeedleTe ... | Grant | A | 0.00 | 15,000 | 0 | 25,000 | 10 K to 25 K (+150.00 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Option Exercise | A | 0.93 | 80,000 | 74,400 | 574,000 | |
Mar 02 2009 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 40,000 | 0 | 399,979 | 360 K to 400 K (+11.11 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | JACOBS M CHRISTINE | Chief Executive Off ... | Grant | A | 0.00 | 19,673 | 0 | 359,979 | 340.3 K to 360 K (+5.78 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | OBANNON MICHAEL | Exc. VP Org. Dev. | Option Exercise | A | 0.93 | 19,000 | 17,670 | 96,000 | |
Mar 02 2009 | TGX | THERAGENICS CORP | OBANNON MICHAEL | Exc. VP Org. Dev. | Grant | A | 0.00 | 8,000 | 0 | 53,204 | 45.2 K to 53.2 K (+17.70 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | OBANNON MICHAEL | Exc. VP Org. Dev. | Grant | A | 0.00 | 4,118 | 0 | 45,204 | 41.1 K to 45.2 K (+10.02 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | Lang Michael Francis | President, Galt Med ... | Option Exercise | A | 0.93 | 34,000 | 31,620 | 63,000 | |
Mar 02 2009 | TGX | THERAGENICS CORP | Lang Michael Francis | President, Galt Med ... | Grant | A | 0.00 | 15,000 | 0 | 28,000 | 13 K to 28 K (+115.38 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Option Exercise | A | 0.93 | 40,000 | 37,200 | 146,200 | |
Mar 02 2009 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 18,000 | 0 | 94,388 | 76.4 K to 94.4 K (+23.56 %) |
Mar 02 2009 | TGX | THERAGENICS CORP | Tarallo Francis J | Chief Financial Off ... | Grant | A | 0.00 | 9,150 | 0 | 75,211 | 66.1 K to 75.2 K (+13.85 %) |